Blood Cancer Journal (Sep 2021)
BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified
- Mario L. Marques-Piubelli,
- Luisa M. Solis,
- Edwin R. Parra,
- Luis Malpica Castillo,
- Sushanth Gouni,
- Ranjit Nair,
- Dai Chihara,
- Marina Konopleva,
- Ignacio I. Wistuba,
- Swaminathan P. Iyer,
- Francisco Vega,
- Paolo Strati
Affiliations
- Mario L. Marques-Piubelli
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center
- Luisa M. Solis
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center
- Edwin R. Parra
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center
- Luis Malpica Castillo
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
- Sushanth Gouni
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
- Ranjit Nair
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
- Dai Chihara
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
- Marina Konopleva
- Department of Leukemia, The University of Texas MD Anderson Cancer Center
- Ignacio I. Wistuba
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center
- Swaminathan P. Iyer
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center
- Francisco Vega
- Department of Hematopathology, The University of Texas MD Anderson Cancer Center
- Paolo Strati
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center
- DOI
- https://doi.org/10.1038/s41408-021-00549-6
- Journal volume & issue
-
Vol. 11,
no. 9
pp. 1 – 4
Abstract
No abstracts available.
